Mankind Pharma Ltd
Mankind Pharma's GHG Emissions Data Preview
In 2025, Mankind Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Mankind Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Verified Sources Behind Mankind Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Mankind Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into Mankind Pharma's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions of Mankind Pharma amounted to 35,743 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Mankind Pharma increased by 27.9%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Mankind Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Mankind Pharma's Scope 1 emissions?
In 2025, the total Scope 1 emissions of Mankind Pharma were 6,538 metric tons of CO₂ equivalent (tCO₂e). a
Has Mankind Pharma reduced its Scope 1 emissions over time?
Since 2022, Mankind Pharma's Scope 1 emissions have decreased by 58.5%, reflecting a declining long-term trend in Scope 1 emissions over time. a c
Compared to the previous year (2024), Mankind Pharma's Scope 1 emissions decreased by 19.03%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Mankind Pharma's Scope 2 emissions?
In 2025, Mankind Pharma reported Scope 2 greenhouse gas (GHG) emissions of 29,205 tCO₂e without specifying the calculation method. a
Has Mankind Pharma reduced its Scope 2 emissions over time?
Since 2022, Mankind Pharma's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Mankind Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a c
Compared to the previous year (2024), Mankind Pharma's Scope 2 emissions (Unspecified Calculation Method) rose by 46.97% in 2025, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does Mankind Pharma use for Scope 2 reporting?
In 2025, Mankind Pharma reported its Scope 2 emissions using an unspecified methodology. a
Mankind Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Mankind Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2025, Mankind Pharma reported Scope 1 greenhouse gas (GHG) emissions of 6,538 tCO₂e and total revenues of USD 1,429 millions. This translates into an emissions intensity of 4.58 tCO₂e per millions USD. a
Mankind Pharma's Scope 1 Emissions Intensity Compared to Peers
How does Mankind Pharma's GHG emissions intensity compare to its peers?
In 2025, Mankind Pharma reported a Scope 1 emissions intensity of 4.58 tCO₂e per millions USD. Compared to the peer group median of 28.64 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does Mankind Pharma rank on GHG emissions intensity within its industry?
In 2025, Mankind Pharma ranked 2 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Mankind Pharma among the top performers, with one of the lowest emissions intensities relative to peers. a